IRA Impact on Biopharma Drug Development

from Rx for Biotech · host Podcast Host Chris Leidli

The Inflation Reduction Act was signed into law in August 2022 and is one of the most significant pieces of healthcare reform since the Affordable Care Act. In this episode, learn more about how the new policy will impact R&D portfolio decision making and new product development strategies.

Episode metadata supplied by the publisher feed · Published Oct 7, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

IRA Impact on Biopharma Drug Development

0:00 10:14

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Rx for Biotech?

This episode is 10 minutes long.

When was this Rx for Biotech episode published?

This episode was published on October 7, 2022.

Can I download this Rx for Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!